Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionRitholtz Wealth Management
Latest Disclosed Ownership139,243 shares
Latest Disclosed Value $ 19,406,263
Ritholtz Wealth Management reports 2.90% increase in ownership of GILD / Gilead Sciences, Inc.

On April 20, 2026 - Ritholtz Wealth Management filed a 13F-HR form disclosing ownership of 139,243 shares of Gilead Sciences, Inc. (CH:GILD) valued at $19,406,263 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 135,318 shares of Gilead Sciences, Inc.. This represents a change in shares of 2.90% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-20 2026-03-31 13F GILEAD SCIENCES COM 375558103 139,243 3,925 2.90 19,406 16.85 0.3366
2026-01-23 2025-12-31 13F GILEAD SCIENCES COM 375558103 135,318 7,865 6.17 16,609 17.40 0.3032
2025-10-28 2025-09-30 13F GILEAD SCIENCES COM 375558103 127,453 12,287 10.67 14,147 10.80 0.2751
2025-07-28 2025-06-30 13F GILEAD SCIENCES COM 375558103 115,166 12,726 12.42 12,768 11.24 0.2819
2025-04-17 2025-03-31 13F GILEAD SCIENCES COM 375558103 102,440 14,212 16.11 11,478 40.85 0.3429
2025-01-15 2024-12-31 13F GILEAD SCIENCES COM 375558103 88,228 39,386 80.64 8,150 99.05 0.2394
2024-10-10 2024-09-30 13F GILEAD SCIENCES COM 375558103 48,842 4,125 9.22 4,095 33.44 0.1234
2024-08-01 2024-06-30 13F GILEAD SCIENCES COM 375558103 44,717 -15,237 -25.41 3,068 -30.13 0.1012
2024-04-24 2024-03-31 13F GILEAD SCIENCES COM 375558103 59,954 -4,088 -6.38 4,392 -15.36 0.1515
2024-01-18 2023-12-31 13F GILEAD SCIENCES COM 375558103 64,042 1,660 2.66 5,188 11.00 0.2013
2023-10-13 2023-09-30 13F GILEAD SCIENCES COM 375558103 62,382 -1,390 -2.18 4,675 -4.88 0.2099
2023-07-17 2023-06-30 13F GILEAD SCIENCES COM 375558103 63,772 -1,713 -2.62 4,915 -9.55 0.2211
2023-04-20 2023-03-31 13F GILEAD SCIENCES COM 375558103 65,485 -2,973 -4.34 5,433 -7.55 0.2708
2023-01-19 2022-12-31 13F GILEAD SCIENCES COM 375558103 68,458 9,832 16.77 5,877 62.48 0.3281
2022-10-19 2022-09-30 13F GILEAD SCIENCES COM 375558103 58,626 49,837 567.04 3,617 566.11 0.1921
2022-07-15 2022-06-30 13F GILEAD SCIENCES COM 375558103 8,789 2,259 34.59 543 39.95 0.0342
2022-04-14 2022-03-31 13F GILEAD SCIENCES COM 375558103 6,530 -3,276 -33.41 388 -45.51 0.0262
2022-01-18 2021-12-31 13F GILEAD SCIENCES COM 375558103 9,806 1,013 11.52 712 15.96 0.0443
2021-10-14 2021-09-30 13F GILEAD SCIENCES COM 375558103 8,793 837 10.52 614 12.04 0.0426
2021-07-20 2021-06-30 13F GILEAD SCIENCES COM 375558103 7,956 -57 -0.71 548 5.79 0.0395
2021-05-12 2021-03-31 13F GILEAD SCIENCES COM 375558103 8,013 8,013 518 0.0431
2021-01-19 2020-12-31 13F GILEAD SCIENCES COM 375558103 0 -3,857 -100.00 0 -100.00
2020-10-23 2020-09-30 13F GILEAD SCIENCES COM 375558103 3,857 -200 -4.93 244 -21.79 0.0274
2020-07-15 2020-06-30 13F GILEAD SCIENCES COM 375558103 4,057 1,134 38.80 312 42.47 0.0402
2020-04-09 2020-03-31 13F GILEAD SCIENCES COM 375558103 2,923 2,923 219 0.0351
2019-10-17 2019-09-30 13F GILEAD SCIENCES COM 375558103 0 -3,551 -100.00 0 -100.00
2019-07-15 2019-06-30 13F GILEAD SCIENCES COM 375558103 3,551 -1,075 -23.24 240 -20.27 0.0410
2019-04-12 2019-03-31 13F GILEAD SCIENCES COM 375558103 4,626 -340 -6.85 301 -3.22 0.0551
2019-01-18 2018-12-31 13F GILEAD SCIENCES COM 375558103 4,966 -509 -9.30 311 -26.48 0.0705
2018-10-12 2018-09-30 13F GILEAD SCIENCES COM 375558103 5,475 -1,151 -17.37 423 -9.81 0.1071
2018-07-12 2018-06-30 13F GILEAD SCIENCES COM 375558103 6,626 -2,399 -26.58 469 -31.03 0.1274
2018-04-17 2018-03-31 13F GILEAD SCIENCES COM 375558103 9,025 -3,425 -27.51 680 -23.77 0.1943
2018-01-23 2017-12-31 13F GILEAD SCIENCES COM 375558103 12,450 12,450 892 0.2643
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.